As of May 22, 2025, Sativa Wellness Group Inc has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.06, this represents a potential upside of -565.1%.
| Key Metrics | Value |
|---|---|
| DCF Fair Value (5-year) | $0.00 |
| DCF Fair Value (10-year) | $0.00 |
| Potential Upside (5-year) | -570.7% |
| Potential Upside (10-year) | -565.1% |
| Discount Rate (WACC) | 6.4% - 10.3% |
Revenue is projected to grow from $2 million in 12-2020 to $3 million by 12-2030, representing a compound annual growth rate of approximately 4.1%.
| Fiscal Year | Revenue (USD millions) | Growth |
|---|---|---|
| 12-2020 | 2 | 611% |
| 12-2021 | 2 | 8% |
| 12-2022 | 2 | 2% |
| 12-2023 | 2 | 3% |
| 12-2024 | 2 | 2% |
| 12-2025 | 2 | 2% |
| 12-2026 | 2 | 2% |
| 12-2027 | 2 | 2% |
| 12-2028 | 3 | 5% |
| 12-2029 | 3 | 2% |
| 12-2030 | 3 | 8% |
Net profit margin is expected to improve from -234% in 12-2020 to -227% by 12-2030, driven by operational efficiency and economies of scale.
| Fiscal Year | Net Profit (USD millions) | Profit Margin |
|---|---|---|
| 12-2020 | (5) | -234% |
| 12-2021 | (5) | -237% |
| 12-2022 | (5) | -235% |
| 12-2023 | (5) | -233% |
| 12-2024 | (5) | -231% |
| 12-2025 | (5) | -229% |
| 12-2026 | (5) | -229% |
| 12-2027 | (6) | -228% |
| 12-2028 | (6) | -228% |
| 12-2029 | (6) | -228% |
| 12-2030 | (6) | -227% |
with a 5-year average of $1 million. Projected CapEx is expected to maintain at approximately 15% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
| Fiscal Year | D&A (USD millions) |
|---|---|
| 12-2021 | 1 |
| 12-2022 | 1 |
| 12-2023 | 1 |
| 12-2024 | 0 |
| 12-2025 | 0 |
| 12-2026 | 0 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
| Components | Average Days |
|---|---|
| Days Receivables | 276 |
| Days Inventory | 752 |
| Days Payables | 0 |
| Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
|---|---|---|---|---|---|
| 3M/2021 | (1) | (0) | 0 | 1 | (2) |
| 2022 | (4) | (0) | 0 | (2) | (3) |
| 2023 | (4) | (0) | 0 | 0 | (5) |
| 2024 | (5) | (0) | 0 | 0 | (6) |
| 2025 | (5) | (0) | 0 | (0) | (5) |
| Valuation Method | Fair Price (USD) | Potential Upside |
|---|---|---|
| 5-Year DCF (Growth) | 0.00 | -570.7% |
| 10-Year DCF (Growth) | 0.00 | -565.1% |
| 5-Year DCF (EBITDA) | 0.00 | -100.0% |
| 10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is Sativa Wellness Group Inc (SWEL.CN) a buy or a sell? Sativa Wellness Group Inc is definitely a sell. Based on our DCF analysis, Sativa Wellness Group Inc (SWEL.CN) appears to be overvalued with upside potential of -565.1%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.06.